Skip to main content

MoneyWorks4Me

Abbott India informs about Board Meeting

04 Jun 2013 Evaluate

Abbott India has informed that the Board of Directors of the Company at its meeting held on June 03, 2013, has decided to defer the proposal received by the Company for the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals division of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1825.35
Dr. Reddys Labs. 1360.80
Cipla 1401.75
Lupin 1987.50
Zydus Lifesciences 1196.40
View more..